Compare EMIS & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMIS | MRCC |
|---|---|---|
| Founded | 2024 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.1M | 151.2M |
| IPO Year | 2025 | 2012 |
| Metric | EMIS | MRCC |
|---|---|---|
| Price | $10.01 | $6.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 58.2K | ★ 93.3K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | ★ 15.77% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,742,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.90 | $5.86 |
| 52 Week High | $11.11 | $8.85 |
| Indicator | EMIS | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.76 |
| Support Level | N/A | $6.65 |
| Resistance Level | N/A | $6.80 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 17.29 |
Emmis Acquisition Corp is a blank check company.
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.